1. Section of Experimental Oncology and Nanomedicine (SEON), ENT Department, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany;
2. INSERM, U1148, LVTS, Paris Diderot University, X Bichat Hospital, Paris, France;
3. Department of Biomaterials Science and Technology, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands;
4. nanoPET Pharma GmbH, Berlin, Germany;
5. Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria;
6. Grenoble Alpes Université, CEA-LETI MINATEC Campus, Grenoble, France;
7. Department of Experimental Molecular Imaging, RWTH University Clinic Aachen, Aachen, Germany;
8. Institute of Biophysics, Medical University of Graz, Graz, Austria